3.00
price down icon51.38%   -3.17
pre-market  Vorhandelsmarkt:  3.09   0.09   +3.00%
loading

Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten

pulisher
Nov 21, 2024

Stock market news: Perspective Therapeutics -44.33%, Pyxis Oncology -42.93% among top losers during mid day trading - Business Upturn

Nov 21, 2024
pulisher
Nov 21, 2024

Stock market news: SKK Holdings Limited declined by 51.53% while SCWorx Corp. surged by 101.02% during mid day trading - Business Upturn

Nov 21, 2024
pulisher
Nov 21, 2024

Stock market today: Pyxis Oncology plunges by 47.25% while Perspective Therapeutics declines by 46.68% in early trading - Business Upturn

Nov 21, 2024
pulisher
Nov 21, 2024

Stock market today: SCWorx Corp. gains 141.81% while Pyxis Oncology down by 46.41% in early trading - Business Upturn

Nov 21, 2024
pulisher
Nov 21, 2024

Perspective stock slips after radio pharma data (CATX:NYSE) - Seeking Alpha

Nov 21, 2024
pulisher
Nov 21, 2024

Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium - The Manila Times

Nov 21, 2024
pulisher
Nov 18, 2024

Cantor Fitzgerald Has Positive View of CATX FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

Is Perspective Therapeutics (CATX) the Best Multibagger Stock to Buy Heading into 2025? - Insider Monkey

Nov 16, 2024
pulisher
Nov 15, 2024

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024 - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Avidity Partners Management LP Bolsters Portfolio with Perspecti - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Analysis of COMMODORE CAPITAL LP's Recent Transaction in Perspec - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey

Nov 14, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC Increases Stake in Perspective Therape - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Perspective Therapeutics' SWOT analysis: radiopharmaceutical stock's potential in focus By Investing.com - Investing.com South Africa

Nov 14, 2024
pulisher
Nov 13, 2024

Perspective Therapeutics' SWOT analysis: radiopharmaceutical stock's potential in focus - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Perspective Therapeutics earnings matched, revenue topped estimates By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Perspective Therapeutics: Q3 Earnings Snapshot - Houston Chronicle

Nov 13, 2024
pulisher
Nov 12, 2024

Perspective Therapeutics Reports Strong Cash Position and Clinical Advances - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Amicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

WealthPlan Investment Management LLC Purchases New Stake in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Perspective Therapeutics Reports $267.8M Cash Position, Advances Cancer Drug Trials | CATX Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 07, 2024

FMR LLC Acquires Shares in Perspective Therapeutics Inc - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

Lantheus Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 06, 2024
pulisher
Nov 05, 2024

Perspective Therapeutics, Inc. (NYSE:CATX) Receives $20.63 Consensus Price Target from Analysts - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Perspective Therapeutics, Inc. (NYSE:CATX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

Perspective Therapeutics management to meet virtually with Cantor Fitzgerald - Nasdaq

Nov 04, 2024
pulisher
Nov 03, 2024

Perspective Therapeutics targeting tumors - The Gazette

Nov 03, 2024
pulisher
Nov 01, 2024

Hills Bank & Trust Co Takes $13.72 Million Position in Perspective Therapeutics, Inc. (NYSE:CATX) - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results - The Manila Times

Oct 31, 2024
pulisher
Oct 30, 2024

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights - Benzinga

Oct 30, 2024
pulisher
Oct 29, 2024

Perspective Therapeutics to Participate in Upcoming Investor Conferences in November - The Manila Times

Oct 29, 2024
pulisher
Oct 28, 2024

Perspective Therapeutics' SWOT analysis: radiopharmaceutical stock's lead-212 edge - Investing.com India

Oct 28, 2024
pulisher
Oct 28, 2024

Nuclear Medicine Market Size & Global Growth Report [2032] - Fortune Business Insights

Oct 28, 2024
pulisher
Oct 25, 2024

1,602,283 Shares in Perspective Therapeutics, Inc. (NYSE:CATX) Purchased by Nicholson Wealth Management Group LLC - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Perspective Therapeutics (NYSE:CATX) Shares Gap UpStill a Buy? - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Perspective Therapeutics initiated with a Buy at UBS - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Perspective Therapeutics (NYSE:CATX) Given Outperform Rating at Wedbush - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Market undervaluing Perspective Therapeutics stock amid upcoming trial data, says UBS - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

Perspective Therapeutics (NYSE:CATX) Now Covered by UBS Group - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Perspective Therapeutics presents updates at 37th Annual Congress of EANM - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Immunodeficiency Therapeutics Market Analysis by Industry - openPR

Oct 23, 2024
pulisher
Oct 22, 2024

Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been enviable, earning 685% in 5 years - Simply Wall St

Oct 22, 2024
pulisher
Oct 22, 2024

Oppenheimer maintains outperform rating on CATX shares amid new data - Investing.com India

Oct 22, 2024
pulisher
Oct 21, 2024

Siemens Healthineers Gets FDA Clearance for Alzheimer’s Disease Analysis Features - Imaging Technology News

Oct 21, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 6,328 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 20, 2024
pulisher
Oct 16, 2024

Perspective Therapeutics Inc (CATX) Shares Up 4.38% on Oct 16 - GuruFocus.com

Oct 16, 2024
pulisher
Oct 16, 2024

Perspective begins shipping investigational products from facility in NJ - TipRanks

Oct 16, 2024
pulisher
Oct 16, 2024

Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey - The Manila Times

Oct 16, 2024
pulisher
Oct 16, 2024

Perspective Therapeutics Begins Shipping Investigational Products from Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey - Marketscreener.com

Oct 16, 2024
medical_devices STE
$215.77
price up icon 1.66%
medical_devices ZBH
$108.40
price down icon 0.80%
medical_devices PHG
$26.38
price up icon 0.27%
$74.46
price down icon 1.04%
$82.00
price down icon 3.42%
medical_devices EW
$70.38
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):